Polish researchers say long-term control of allergic asthma can occur after only three years of allergy shots -- not the recommended three to five years. Dr. Iwona Stelmach of the Medical University of Lodz in Poland and colleagues said immunotherapy, or allergy shots, can alter the progression of allergic disease. Treatment, Stelmach said, alleviates patients of symptoms, while preventing asthma and the development of other allergies. "The recommended duration of immunotherapy for long-term effectiveness has been three to five years," Stelmach, the study's lead author, said in a statement. "Our research shows that three years is an adequate duration for the treatment of childhood asthma associated with house dust mites. An additional two years adds no clinical benefit." Dr. James Sublett, an allergist who is chairman of the American College of Allergy, Asthma and Immunology's Indoor Environment Committee, said not only does the shorter period of shots provide long-term therapeutic benefits for both children and adults, it can reduce total healthcare costs by 33 percent to 41 percent. "It has long been observed that the effectiveness of allergy shots continue long after treatment has been completed," Sublett said. " The findings were published in the of the Annals of Allergy, Asthma and Immunology.
GMT 10:31 2018 Tuesday ,13 November
Russian police uproot 70 underground drug labs in past six monthsGMT 16:32 2018 Tuesday ,06 November
Rwanda aims to achieve universal access to clean water by 2024GMT 16:57 2018 Sunday ,04 November
Palestinian women witness higher cure rate of breast cancerGMT 13:11 2018 Tuesday ,30 October
Emergency surgery saves life of touristGMT 10:44 2018 Tuesday ,23 October
Scientists find microplastics in human stool for first timeGMT 09:18 2018 Tuesday ,23 October
US judge upholds Monsanto weedkiller cancer verdict, reduces payoutGMT 14:22 2018 Friday ,19 October
Birth spacing ‘improving health of Omani women’GMT 15:40 2018 Monday ,15 October
Pakistani president launches nationwide anti-measles driveMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor